Tips for Pharmaceutical Manufacturing Scale-Up & Tech Transfer

During the pilot to commercial scale transition of a monoclonal antibody (mAb) product, the quality control (QC) team observed an outlier in the potency assay results. The following symptoms were…

The production floor may exhibit various signals indicating potential hold time risks, such as:Click to read the full article.

Identifying symptoms or signals associated with equipment capacity risks during the pilot to commercial scale transition is crucial. Observing the following indicators on the manufacturing floor or in the laboratory…

Identifying symptoms early is vital in addressing yield loss efficiently. Here are common signals that may indicate issues during the commercial scale-up transition:Click to read the full article.

Recognizing the signs of yield loss is critical for swift action. Here are typical symptoms that may indicate underlying issues:Click to read the full article.

Dissolution drift may not always be immediately apparent; however, certain symptoms can signal potential issues during the scale-up phase:Click to read the full article.

During routine quality control (QC) testing of the first commercial batch of a recently scaled-up tablet formulation, several alarming signals were observed:Click to read the full article.

Identifying symptoms that indicate potential sterility assurance issues is the first step toward mitigating risks during scale-up. Some common signals include:Click to read the full article.

Different failure signals might indicate issues in the scale-up process. These can arise in various formats and should never be overlooked. Common symptoms include:Click to read the full article.

Identifying deviations early increases the likelihood of successful interventions. Here are common symptoms that may indicate a deviation has occurred:Click to read the full article.

Best Practices for Handling Deviations During the Transition from Pilot to Commercial Scale Transitioning from pilot to commercial scale in pharmaceutical manufacturing entails various risks and complexities that can lead…

Symptoms indicating potential issues during the scale-up transition to commercial manufacturing are critical for timely interventions. Common signals include:Click to read the full article.